Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Harbour JW – Many cytogenetic and molecular prognostic tests for uveal melanoma have been reported, yet few have reached the standards required for routine clinical testing. Clinicians must understand the statistical and scientific limitations of the tests they are using, and appropriate ethical oversight is essential until such time that validated testing instruments are available that are performed in a standardized clinical testing environment.

Related Articles

A reappraisal of the significance of largest basal diameter of posterior uveal melanoma
Eye, 11/02/09    Relevance Score: 68%

Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease
Current Opinion in Ophthalmology, 10/27/09    Relevance Score: 67%

Surgical management of liver metastases from uveal melanoma: 16 years experience at the Institut Curie
European Journal of Surgical Oncology, 10/21/09    Relevance Score: 67%

Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey
Investigative Ophthalmology and Visual Science, 10/15/09    Relevance Score: 67%

Immunohistochemical assessment of mitotic count in uveal melanoma
Acta Ophthalmologica, 11/13/09    Relevance Score: 66%

Today in Oncology...keeping you current

Human papillomavirus infection and squamous cell carcinoma of the conjunctiva
British Journal of Cancer, 12/10/09

Conjunctival intra-epithelial neoplasia occurring in young patients with asthma
Eye, 12/08/09

Genetics of uveal melanoma
Expert Review of Ophthalmology, 12/07/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address